Measuring the Plasmodium falciparum HRP2 protein in blood from artesunate-treated malaria patients predicts post-artesunate delayed hemolysis

Artesunate, the recommended drug for severe malaria, rapidly clears the malaria parasite from infected patients but frequently induces anemia-called post-artesunate delayed hemolysis (PADH)-for which a simple predictive test is urgently needed. The underlying event in PADH is the expulsion of artesu...

Full description

Bibliographic Details
Main Authors:	Ndour, P, Larréché, S, Mouri, O, Argy, N, Gay, F, Roussel, C, Jauréguiberry, S, Perillaud, C, Langui, D, Biligui, S, Chartrel, N, Mérens, A, Kendjo, E, Ghose, A, Hassan, M, Hossain, M, Kingston, H, Plewes, K, Dondorp, A, Danis, M, Houzé, S, Bonnefoy, S, Thellier, M, Woodrow, C, Buffet, P, French Artesunate Working Group
Format:	Journal article
Language:	English
Published:	American Association for the Advancement of Science 2017

Measuring the Plasmodium falciparum HRP2 protein in blood from artesunate-treated malaria patients predicts post-artesunate delayed hemolysis

Similar Items